Table of Contents 2012-2023 Global Overactive Bladder Therapeutics Market Research Report by Manufacturers, Regions, Types and Applications 1 Overactive Bladder Therapeutics Market Overview 1.1 Product Overview and Scope of Overactive Bladder Therapeutics 1.2 Overactive Bladder Therapeutics Segment by Type (Product Category) 1.2.1 Overactive Bladder Therapeutics Segment by Types (Product Category) and Its Subclasses 1.2.2 Global Overactive Bladder Therapeutics Production Market Share by Type (Product Category) in 2016 1.2.3 Different Subclasses for Anti-Muscarinic Agent 1.2.3.1 Subclass 1 1.2.3.2 Subclass 2 1.2.3.3 Subclass 3 1.2.4 Different Subclasses for Beta-3-Adrenergic Receptor Agonist 1.2.4.1 Subclass 1 1.2.4.2 Subclass 2 1.2.4.3 Subclass 3 1.2.5 Different Subclasses for Others 1.2.5.1 Subclass 1 1.2.5.2 Subclass 2 1.2.5.3 Subclass 3 1.3 Global Overactive Bladder Therapeutics Segment by Application 1.3.1 Global Overactive Bladder Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Medical Care 1.3.3 Medical Research 1.3.4 Others 1.4 New Project SWOT Analysis of Overactive Bladder Therapeutics 1.5 Industry News Analysis of Overactive Bladder Therapeutics 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Overactive Bladder Therapeutics 2.2 Raw Material Analysis of Overactive Bladder Therapeutics 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Overactive Bladder Therapeutics 2.4 Other Costs Analysis of Overactive Bladder Therapeutics 2.5 Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics 2.6 Manufacturing Process Analysis of Overactive Bladder Therapeutics 2.7 Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2017 2.8 Downstream Buyers of Overactive Bladder Therapeutics 3 Global Overactive Bladder Therapeutics Manufacturers Profiles/Analysis 3.1 Actavis 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.1.2.1 Anti-Muscarinic Agent 3.1.2.2 Beta-3-Adrenergic Receptor Agonist 3.1.2.3 Others 3.1.3 Actavis Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Actavis Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Actavis Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.2 Allergan 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.2.2.1 Anti-Muscarinic Agent 3.2.2.2 Beta-3-Adrenergic Receptor Agonist 3.2.2.3 Others 3.2.3 Allergan Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Allergan Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Allergan Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.3 Astellas Pharma 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.3.2.1 Anti-Muscarinic Agent 3.3.2.2 Beta-3-Adrenergic Receptor Agonist 3.3.2.3 Others 3.3.3 Astellas Pharma Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Astellas Pharma Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Astellas Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.4 Pfizer 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.4.2.1 Anti-Muscarinic Agent 3.4.2.2 Beta-3-Adrenergic Receptor Agonist 3.4.2.3 Others 3.4.3 Pfizer Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Pfizer Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Pfizer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.5 Addex Pharmaceuticals Ltd 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.5.2.1 Anti-Muscarinic Agent 3.5.2.2 Beta-3-Adrenergic Receptor Agonist 3.5.2.3 Others 3.5.3 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Addex Pharmaceuticals Ltd Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.6 Bayer 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.6.2.1 Anti-Muscarinic Agent 3.6.2.2 Beta-3-Adrenergic Receptor Agonist 3.6.2.3 Others 3.6.3 Bayer Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Bayer Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Bayer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.7 Elbion 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.7.2.1 Anti-Muscarinic Agent 3.7.2.2 Beta-3-Adrenergic Receptor Agonist 3.7.2.3 Others 3.7.3 Elbion Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Elbion Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Elbion Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.8 Ipsen 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.8.2.1 Anti-Muscarinic Agent 3.8.2.2 Beta-3-Adrenergic Receptor Agonist 3.8.2.3 Others 3.8.3 Ipsen Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Ipsen Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Ipsen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.9 Janssen 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.9.2.1 Anti-Muscarinic Agent 3.9.2.2 Beta-3-Adrenergic Receptor Agonist 3.9.2.3 Others 3.9.3 Janssen Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Janssen Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Janssen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.10 Kissei Pharma 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.10.2.1 Anti-Muscarinic Agent 3.10.2.2 Beta-3-Adrenergic Receptor Agonist 3.10.2.3 Others 3.10.3 Kissei Pharma Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Kissei Pharma Different Types of Overactive Bladder Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Kissei Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 4 Global Overactive Bladder Therapeutics Market Competition by Manufacturers 4.1 Global Overactive Bladder Therapeutics Capacity, Production and Share by Manufacturers (2012-2017) 4.1.1 Global Overactive Bladder Therapeutics Capacity (K Units) and Share (%) by Manufacturers (2012-2017) 4.1.2 Global Overactive Bladder Therapeutics Production (K Units) and Share (%) by Manufacturers (2012-2017) 4.2 Global Overactive Bladder Therapeutics Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Global Overactive Bladder Therapeutics Average Price (USD/Unit) by Manufacturers (2012-2017) 4.4 Manufacturers Overactive Bladder Therapeutics Manufacturing Base Distribution, Sales Area, Product Types 4.5 Overactive Bladder Therapeutics Market Competitive Situation and Trends 4.5.1 Overactive Bladder Therapeutics Market Concentration Rate 4.5.2 Overactive Bladder Therapeutics Market Share (%) of Top 3 and Top 5 Manufacturers 5 Global Overactive Bladder Therapeutics Production by Regions (2012-2017) 5.1 Global Overactive Bladder Therapeutics Capacity (K Units) and Market Share (%) by Regions (2012-2017) 5.2 Global Overactive Bladder Therapeutics Production (K Units) and Market Share (%) by Regions (2012-2017) 5.3 Global Overactive Bladder Therapeutics Revenue and Market Share (%) by Regions (2012-2017) 5.4 Global Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.5 North America Overactive Bladder Therapeutics Production (2012-2017) 5.5.1 North America Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.5.2 North America Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.6 Europe Overactive Bladder Therapeutics Production (2012-2017) 5.6.1 Europe Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.6.2 Europe Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.7 China Overactive Bladder Therapeutics Production (2012-2017) 5.7.1 China Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.7.2 China Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.8 Japan Overactive Bladder Therapeutics Production (2012-2017) 5.8.1 Japan Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.8.2 Japan Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.9 Southeast Asia Overactive Bladder Therapeutics Production (2012-2017) 5.9.1 Southeast Asia Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.9.2 Southeast Asia Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.10 India Overactive Bladder Therapeutics Production (2012-2017) 5.10.1 India Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.10.2 India Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 6 Global Overactive Bladder Therapeutics Consumption (K Units) by Regions (2012-2017) 6.1 Global Overactive Bladder Therapeutics Consumption (K Units) by Regions (2012-2017) 6.2 North America Overactive Bladder Therapeutics Consumption (K Units) by Regions (2012-2017) 6.3 Europe Overactive Bladder Therapeutics Consumption (K Units) by Regions (2012-2017) 6.4 China Overactive Bladder Therapeutics Consumption (K Units) by Regions (2012-2017) 6.5 Japan Overactive Bladder Therapeutics Consumption (K Units) by Regions (2012-2017) 7 Global Overactive Bladder Therapeutics Production, Revenue, Price Trend by Types 7.1 Global Overactive Bladder Therapeutics Production (K Units) and Market Share (%) by Types (2012-2017) 7.2 Global Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) by Types (2012-2017) 7.3 Global Overactive Bladder Therapeutics Price (USD/Unit) by Type (2012-2017) 7.4 Global Overactive Bladder Therapeutics Production Growth (%) by Type (2012-2017) 8 Global Market Analysis by Applications 8.1 Global Consumption (K Units) and Market Share (%) by Applications (2012-2017) 8.2 Global Consumption Growth Rate by Applications (2012-2017) 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Global Overactive Bladder Therapeutics Market Forecast (2018-2023) 10.1 Global Overactive Bladder Therapeutics Capacity, Production, Revenue Forecast (2018-2023) 10.1.1 Global Overactive Bladder Therapeutics Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) 10.1.2 Global Overactive Bladder TherapeuticsRevenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 10.1.3 Global Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) 10.2 Global Overactive Bladder Therapeutics Production (K Units) Forecast by Regions (2018-2023) 10.2.1 North America Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.2 Europe Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.3 China Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.4 Japan Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.5 Southeast Asia Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.6 India Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.3 Global Overactive Bladder Therapeutics Consumption (K Units) Forecast by Regions (2018-2023) 10.3.1 North America Overactive Bladder Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.2 Europe Overactive Bladder Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.3 China Overactive Bladder Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.4 Japan Overactive Bladder Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.5 Southeast Asia Overactive Bladder Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.6 India Overactive Bladder Therapeutics Consumption (K Units) Forecast (2018-2023) 10.4 Global Overactive Bladder Therapeutics Production, Revenue and Price Forecast by Type (2018-2023) 10.5 Global Overactive Bladder Therapeutics Consumption Forecast by Application (2018-2023) 11 Research Findings and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Disclaimer 12.4 Author List

List of Tables and Figures Figure Global Overactive Bladder Therapeutics Market Size (Million USD) Status and Outlook 2012-2023 Table Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Overactive Bladder Therapeutics Consumption (K Units) by Application (2017-2023) Figure Picture of Overactive Bladder Therapeutics Figure Global Overactive Bladder Therapeutics Production Market Share (%) by Types in 2016 Figure Global Overactive Bladder Therapeutics Production Market Share (%) by Subclasses of Anti-Muscarinic Agent in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Overactive Bladder Therapeutics Production Market Share (%) by Subclasses of Beta-3-Adrenergic Receptor Agonist in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Overactive Bladder Therapeutics Production Market Share (%) by Subclasses of Others in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Table Global Overactive Bladder Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) Table Global Overactive Bladder Therapeutics Consumption (USD/Unit) Market Share (%) by Applications in 2016 Figure Medical Care Examples Figure Medical Research Examples Figure Others Examples Figure New Project SWOT Analysis of Overactive Bladder Therapeutics Table Industry News List of Overactive Bladder Therapeutics Figure Industry Chain Structure of Overactive Bladder Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/Unit) Figure Global Raw Material B Price Trend (USD/Unit) Figure Global Raw Material C Price Trend (USD/Unit) Table Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics in 2017 Figure Manufacturing Process Analysis of Overactive Bladder Therapeutics Table Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2017 Table Major Buyers of Overactive Bladder Therapeutics Table Actavis Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Actavis Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Actavis Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in and Its Application Share Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Allergan Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Allergan Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in and Its Application Share Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Astellas Pharma Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Pfizer Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in and Its Application Share Table Addex Pharmaceuticals Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in and Its Application Share Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Bayer Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Elbion Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Elbion Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Elbion Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in and Its Application Share Table Ipsen Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Ipsen Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure Ipsen Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Ipsen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in and Its Application Share Table Janssen Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Janssen Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in and Its Application Share Table Kissei Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Kissei Pharma Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure Kissei Pharma Overactive Bladder Therapeutics Production Growth Rate (%) (2012-2017) Figure Kissei Pharma Overactive Bladder Therapeutics Production Market Share (%) (2012-2017) Figure Kissei Pharma Overactive Bladder Therapeutics Revenue Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Kissei Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Kissei Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table Global Overactive Bladder Therapeutics Capacity (K Units) of Key Manufacturers (2012-2017) Table Global Overactive Bladder Therapeutics Capacity Market Share (%) of Key Manufacturers (2012-2017) Figure Global Overactive Bladder Therapeutics Capacity Market Share (%) of Key Manufacturers in 2017 Figure Global Overactive Bladder Therapeutics Capacity Market Share (%) of Key Manufacturers in 2017 Table Global Overactive Bladder Therapeutics Production (K Units) of Key Manufacturers (2012-2017) Table Global Overactive Bladder Therapeutics Production Share (%) by Manufacturers (2012-2017) Figure 2016 Overactive Bladder Therapeutics Production Share (%) by Manufacturers Figure 2016 Overactive Bladder Therapeutics Production Share (%) by Manufacturers Table Global Overactive Bladder Therapeutics Revenue (Million USD) by Manufacturers (2012-2017) Table Global Overactive Bladder Therapeutics Revenue Share (%) by Manufacturers (2012-2017) Table 2016 Global Overactive Bladder Therapeutics Revenue Share (%) by Manufacturers Table 2016 Global Overactive Bladder Therapeutics Revenue Share (%) by Manufacturers Table Global Market Overactive Bladder Therapeutics Average Price (USD/Unit) of Key Manufacturers (2012-2017) Figure Global Market Overactive Bladder Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2017 Table Manufacturers Overactive Bladder Therapeutics Manufacturing Base Distribution and Sales Area Table Manufacturers Overactive Bladder Therapeutics Product Category Figure Overactive Bladder Therapeutics Market Share (%) of Top 3 Manufacturers Figure Overactive Bladder Therapeutics Market Share (%) of Top 5 Manufacturers Table Global Overactive Bladder Therapeutics Capacity (K Units) by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Capacity Market Share (%) by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Capacity Market Share (%) by Regions (2012-2017) Figure 2016 Global Overactive Bladder Therapeutics Capacity Market Share (%) by Regions Table Global Overactive Bladder Therapeutics Production (K Units) by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Production Market Share (%) by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Production Market Share (%) by Regions (2012-2017) Figure 2016 Global Overactive Bladder Therapeutics Production Market Share (%) by Regions Table Global Overactive Bladder Therapeutics Revenue (Million USD) by Regions (2012-2017) Table Global Overactive Bladder Therapeutics Revenue Market Share (%) by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Revenue Market Share (%) by Regions (2012-2017) Figure 2016 Global Overactive Bladder Therapeutics Revenue Market Share (%) by Regions Figure Global Overactive Bladder Therapeutics Capacity, Production (K Units) and Growth Rate (2012-2017) Table Global Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure North America Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table North America Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Europe Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table Europe Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure China Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table China Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Japan Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table Japan Overactive Bladder Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Table Global Overactive Bladder Therapeutics Consumption (K Units) Market by Regions (2012-2017) Table Global Overactive Bladder Therapeutics Consumption Market Share (%) by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Consumption Market Share (%) by Regions (2012-2017) Figure 2016 Global Overactive Bladder Therapeutics Consumption Market Share (%) by Regions Figure North America Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Europe Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure China Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Japan Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Southeast Asia Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure India Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure South America Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Middle East Overactive Bladder Therapeutics Consumption and Growth Rate (%) (2012-2017) Table Global Overactive Bladder Therapeutics Production (K Units) by Types (2012-2017) Table Global Overactive Bladder Therapeutics Production Share (%) by Types (2012-2017) Figure Production Market Share (%) of Overactive Bladder Therapeutics by Types (2012-2017) Figure 2016 Production Market Share (%) of Overactive Bladder Therapeutics by Types Table Global Overactive Bladder Therapeutics Revenue (Million USD) by Types (2012-2017) Table Global Overactive Bladder Therapeutics Revenue Share (%) by Types (2012-2017) Figure Revenue Share (%) of Overactive Bladder Therapeutics by Types (2012-2017) Figure 2016 Revenue Market Share (%) of Overactive Bladder Therapeutics by Types Table Global Overactive Bladder Therapeutics Price (USD/Unit) by Types (2012-2017) Figure Global Overactive Bladder Therapeutics Production Growth (%) by Type (2012-2017) Table Global Overactive Bladder Therapeutics Consumption (K Units) by Applications (2012-2017) Table Global Overactive Bladder Therapeutics Consumption Market Share (%) by Applications (2012-2017) Figure Global Overactive Bladder Therapeutics Consumption Market Share (%) by Applications (2012-2017) Figure Global Overactive Bladder Therapeutics Consumption Market Share (%) by Applications in 2017 Table Global Overactive Bladder Therapeutics Consumption Growth Rate by Applications (2012-2017) Figure Global Overactive Bladder Therapeutics Consumption Growth Rate by Applications (2012-2017) Table Distributors/Traders List Figure Global Overactive Bladder Therapeutics Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Global Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Global Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) Table Global Overactive Bladder Therapeutics Production (K Units) Forecast by Regions (2018-2023) Figure Global Overactive Bladder Therapeutics Production Market Share (%) Forecast by Regions (2018-2023) Figure North America Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Overactive Bladder Therapeutics Production (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Global Overactive Bladder Therapeutics Consumption (K Units) Forecast by Regions (2018-2023) Figure Global Overactive Bladder Therapeutics Consumption Market Share (%) Forecast by Regions (2018-2023) Figure North America Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South America Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Middle East Overactive Bladder Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Table Global Overactive Bladder Therapeutics Production (K Units) Forecast by Type (2018-2023) Figure Global Overactive Bladder Therapeutics Production Forecast by Type (2018-2023) Table Global Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure Global Overactive Bladder Therapeutics Revenue Market Share (%) Forecast by Type (2018-2023) Table Global Overactive Bladder Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table Global Overactive Bladder Therapeutics Consumption (K Units) Forecast by Application (2018-2023) Figure Global Overactive Bladder Therapeutics Consumption Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Actavis Allergan Astellas Pharma Pfizer Addex Pharmaceuticals Ltd Bayer Elbion Ipsen Janssen Kissei Pharma